Herpes Simplex Viruses Whose Replication Can Be Deliberately Controlled as Candidate Vaccines
Over the last few years, we have been evaluating a novel paradigm for immunization using viruses or virus-based vectors. Safety is provided not by attenuation or inactivation of vaccine viruses, but by the introduction into the viral genomes of genetic mechanisms that allow for stringent, deliberate...
Main Authors: | Richard Voellmy, David C Bloom, Nuria Vilaboa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/8/2/230 |
Similar Items
-
Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses
by: Brent A. Stanfield, et al.
Published: (2021-08-01) -
Immunization with a highly attenuated replication-competent herpes simplex virus type 1 mutant, HF10, protects mice from genital disease caused by herpes simplex virus type 2
by: Chenhong eLuo, et al.
Published: (2012-04-01) -
Ups and downs in the search for a Herpes simplex virus vaccine
by: Silvia Bolland, et al.
Published: (2015-03-01) -
Vaccination Route as a Determinant of Protective Antibody Responses against Herpes Simplex Virus
by: Clare Burn Aschner, et al.
Published: (2020-06-01) -
Development of Recombinant Vaccine Using Herpesvirus of Turkey (Hvt) as Vector for Several Viral Diseases in Poultry Industry
by: Risza Hartawan
Published: (2011-03-01)